(Updated - February 23, 2022 6:14 AM EST)

UBS analyst Kevin Caliendo downgraded Quest Diagnostics (NYSE: DGX) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE